Its main mechanism of action is the specific inhibition of MCT1, which leads to the accumulation of intracellular lactic acid and reduction of intracellular PH, and feedback inhibition of glycolysis, thereby inhibiting the proliferation of tumor cells (Doherty et al., 2014). The gene discussed is SLC16A1; the disease is neoplasm.